Stockreport

Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference

Humacyte, Inc.  (HUMA) 
PDF DURHAM, N.C., March 01, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bio [Read more]